Artivion Return on Tangible Equity 2010-2024 | AORT
Current and historical return on tangible equity values for Artivion (AORT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Artivion Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $0.00B | $-0.11B | 0.00% |
| 2024-06-30 | $-0.01B | $-0.11B | 6.25% |
| 2024-03-31 | $-0.01B | $-0.12B | 6.68% |
| 2023-12-31 | $-0.03B | $-0.14B | 21.87% |
| 2023-09-30 | $-0.03B | $-0.14B | 17.51% |
| 2023-06-30 | $-0.03B | $-0.14B | 19.76% |
| 2023-03-31 | $-0.03B | $-0.15B | 20.20% |
| 2022-12-31 | $-0.02B | $-0.14B | 12.79% |
| 2022-09-30 | $-0.04B | $-0.16B | 27.20% |
| 2022-06-30 | $-0.02B | $-0.15B | 10.79% |
| 2022-03-31 | $-0.01B | $-0.15B | 9.11% |
| 2021-12-31 | $-0.01B | $-0.15B | 8.70% |
| 2021-09-30 | $0.00B | $-0.15B | -1.84% |
| 2021-06-30 | $-0.01B | $-0.17B | 6.71% |
| 2021-03-31 | $-0.01B | $-0.18B | 9.83% |
| 2020-12-31 | $-0.02B | $-0.16B | 16.43% |
| 2020-09-30 | $-0.02B | $-0.15B | 19.05% |
| 2020-06-30 | $-0.01B | $-0.04B | 21.72% |
| 2020-03-31 | $-0.01B | $-0.06B | 8.37% |
| 2019-12-31 | $0.00B | $-0.06B | -3.21% |
| 2019-09-30 | $0.00B | $-0.06B | -6.06% |
| 2019-06-30 | $0.00B | $-0.06B | -5.73% |
| 2019-03-31 | $0.00B | $-0.07B | -1.31% |
| 2018-12-31 | $-0.00B | $-0.07B | 3.68% |
| 2018-09-30 | $-0.01B | $-0.08B | 8.16% |
| 2018-06-30 | $-0.01B | $-0.09B | 12.90% |
| 2018-03-31 | $-0.00B | $-0.09B | 50.00% |
| 2017-12-31 | $0.00B | $-0.09B | 8.76% |
| 2017-09-30 | $0.01B | $0.08B | 12.33% |
| 2017-06-30 | $0.01B | $0.08B | 16.30% |
| 2017-03-31 | $0.01B | $0.07B | 16.26% |
| 2016-12-31 | $0.01B | $0.06B | 19.56% |
| 2016-09-30 | $0.01B | $0.06B | 15.44% |
| 2016-06-30 | $0.01B | $0.05B | 11.56% |
| 2016-03-31 | $0.01B | $0.05B | 6.80% |
| 2015-12-31 | $0.00B | $0.12B | 3.33% |
| 2015-09-30 | $0.00B | $0.12B | 2.54% |
| 2015-06-30 | $0.00B | $0.12B | 2.58% |
| 2015-03-31 | $0.01B | $0.12B | 5.22% |
| 2014-12-31 | $0.01B | $0.12B | 6.14% |
| 2014-09-30 | $0.01B | $0.11B | 12.42% |
| 2014-06-30 | $0.02B | $0.11B | 13.70% |
| 2014-03-31 | $0.02B | $0.11B | 14.25% |
| 2013-12-31 | $0.02B | $0.11B | 15.92% |
| 2013-09-30 | $0.01B | $0.10B | 9.38% |
| 2013-06-30 | $0.01B | $0.10B | 8.58% |
| 2013-03-31 | $0.01B | $0.09B | 9.89% |
| 2012-12-31 | $0.01B | $0.09B | 8.70% |
| 2012-09-30 | $0.01B | $0.09B | 8.60% |
| 2012-06-30 | $0.01B | $0.09B | 8.49% |
| 2012-03-31 | $0.01B | $0.10B | 7.31% |
| 2011-12-31 | $0.01B | $0.10B | 8.18% |
| 2011-09-30 | $0.01B | $0.10B | 8.02% |
| 2011-06-30 | $0.00B | $0.09B | 2.94% |
| 2011-03-31 | $0.00B | $0.11B | 3.76% |
| 2010-12-31 | $0.00B | $0.11B | 3.76% |
| 2010-09-30 | $0.00B | $0.10B | 3.77% |
| 2010-06-30 | $0.01B | $0.11B | 8.55% |
| 2010-03-31 | $0.01B | $0.11B | 8.78% |
| 2009-12-31 | $0.01B | $0.10B | 9.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.208B | $0.354B |
| Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.048B | 99.11 |
| Thermo Fisher Scientific (TMO) | United States | $205.720B | 24.60 |
| Alcon (ALC) | Switzerland | $44.180B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.064B | 28.51 |
| IDEXX Laboratories (IDXX) | United States | $37.082B | 42.44 |
| DexCom (DXCM) | United States | $34.912B | 54.15 |
| IQVIA Holdings (IQV) | United States | $34.165B | 18.93 |
| Mettler-Toledo (MTD) | United States | $27.257B | 31.66 |
| Waters (WAT) | United States | $22.611B | 32.08 |
| STERIS (STE) | Ireland | $21.693B | 24.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.328B | 0.00 |
| Hologic (HOLX) | United States | $14.433B | 15.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.462B | 13.82 |
| Penumbra (PEN) | United States | $11.675B | 105.62 |
| Sysmex ADR (SSMXY) | Japan | $11.519B | 36.12 |
| Globus Medical (GMED) | United States | $11.454B | 26.79 |
| Masimo (MASI) | United States | $9.488B | 45.91 |
| Glaukos (GKOS) | United States | $8.676B | 0.00 |
| Teleflex (TFX) | United States | $8.134B | 12.97 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.536B | 25.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.412B | 0.00 |
| Veracyte (VCYT) | United States | $3.181B | 95.46 |
| Nihon Kohden (NHNKY) | Japan | $2.671B | 14.60 |
| LivaNova (LIVN) | United Kingdom | $2.606B | 15.04 |
| TransMedics (TMDX) | United States | $2.532B | 80.27 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 21.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.110B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.700B | 8.88 |
| Alphatec Holdings (ATEC) | United States | $1.512B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.230B | 0.00 |
| RxSight (RXST) | United States | $1.222B | 0.00 |
| OPKO Health (OPK) | United States | $1.140B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.894B | 0.00 |
| AxoGen (AXGN) | United States | $0.814B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.793B | 17.33 |
| SiBone (SIBN) | United States | $0.755B | 0.00 |
| IRadimed (IRMD) | United States | $0.724B | 38.09 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.711B | 12.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.497B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| ClearPoint Neuro (CLPT) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.425B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.363B | 19.47 |
| Anteris Technologies Global (AVR) | Australia | $0.297B | 0.00 |
| Inogen (INGN) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.222B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 13.90 |
| Lucid Diagnostics (LUCD) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| Hyperfine (HYPR) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 32.14 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |